Your browser doesn't support javascript.
loading
Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
Feng, J-Y; Jarlsberg, L G; Salcedo, K; Rose, J; Janes, M; Lin, S-Y G; Osmond, D H; Jost, K C; Soehnlen, M K; Flood, J; Graviss, E A; Desmond, E; Moonan, P K; Nahid, P; Hopewell, P C; Kato-Maeda, M.
Afiliación
  • Feng JY; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA, Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Institute of Clin
  • Jarlsberg LG; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Salcedo K; Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, California.
  • Rose J; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Janes M; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Lin SG; Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, California.
  • Osmond DH; Department of Epidemiology and Biostatistics, University of California, San Francisco, California.
  • Jost KC; Mycobacteriology/Mycology Group, Texas Department of State Health Services, Austin, Texas.
  • Soehnlen MK; Microbiology Section, Michigan Department of Health and Human Services, Lansing, Michigan.
  • Flood J; Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, California.
  • Graviss EA; Houston Methodist Research Institute Molecular Tuberculosis Laboratory, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas.
  • Desmond E; Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, California.
  • Moonan PK; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Nahid P; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Hopewell PC; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Kato-Maeda M; Curry International Tuberculosis Center, and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
Int J Tuberc Lung Dis ; 21(7): 766-773, 2017 07 01.
Article en En | MEDLINE | ID: mdl-28513421
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Int J Tuberc Lung Dis Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Int J Tuberc Lung Dis Año: 2017 Tipo del documento: Article